This proposal seeks continued support for the Yale research-training program in Diabetes Mellitus and Disorders of Metabolism. This program seves as the core of support for postdoctoral research training in diabetes and metabolic diseases at the Yale School of Medicine. A major goal of the program is to provide physicians and scientists with the research expertise required to pursue clinical, translational and basic research in an academic setting. Physician trainees entering the program will have M.D. or M.D., Ph.D. degress and at least 2-3 years of clinical training in internal medicine or pediatrics. Ph.D. scientist are also recruited into the program since we believe an integrated training experience bringing together adult endocrinologists, pediatric endocrinologists and endocrine scientists is necessary to prepare our trainees to participate in modern multidisciplinary research groups. Trainees are selected based on their aptitude and commitment to a research career. The duration of the training period is three years to ensure an in-depth training experience leading to the ability to pursue an independent research career. The cornerstone of the curriculum is the participation of each trainee in a specific research project under the supervision of a designated preceptor and guided by a progress committee composed of 2-3 other members of the training faculty. Potential projects run the gamut from clinical to basic research in 3 primary areas of emphasis: 1) type 1 diabetes, 2) type 2 diabetes, and 3) bone and mineral metabolism. Within these areas, trainees have the opportunity to work with mentors in several basic science departments as well as those in Pediatrics and Medicine. Close interactions among preceptors and trainees within each programmatic area are enhanced by the interdepartmental Diabetes Research Center adminstered within the Endocrine Section, which further enriches the training experience. Multiple educational opportunities including two degree- granting (MS, PhD) programs are available to trainees through the CTSA-funded Yale Center for Clinical Investigation. Instruction is also provided through organized lectures, research seminars and journal clubs. The application requests a continued allotment of 6 stipends per year to support the combined Adult and Pediatric Training Program instituted in the last funding cycle. Our request is based on our long history of maintaining an outstanding track record of training successful investigators who remain in academic research careers, our ongoing ability to attract outstanding applicants, the high level of research productivity of our training faculty, the expansive palette of research opportunities provided by our diverse faculty and the continued shortage of physician-scientists and scientists in both medicine and pediatrics that are dedicated to research careers in diabetes and metabolic diseases.

Public Health Relevance

Obesity, diabetes and osteoporosis are increaingly prevalent metabolic diseases that are reponsible for a great burden of suffering and death as well as large healthcare expenditures in the US and throughout the world. Academic endocrine researchers are needed in order to better understand these diseases and to translate research findings into new and improved therapies. Our training program in Diabetes and Disorders of Metabolism is dedicated to providing young physicians and scientists with the research training necessary to tackle these important public health problems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007058-46
Application #
9972892
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1975-07-01
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
46
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Erie, Christine; Van Name, Michelle A; Weyman, Kate et al. (2018) Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings. Pediatr Diabetes 19:92-97
Hwang, Janice J; Jiang, Lihong; Hamza, Muhammad et al. (2017) The human brain produces fructose from glucose. JCI Insight 2:e90508
Naushad, Nida; Perdigoto, Ana Luisa; Rui, Jinxiu et al. (2017) Have we pushed the needle for treatment of Type 1 diabetes? Curr Opin Immunol 49:44-50
Sanchez-Rangel, Elizabeth; Inzucchi, Silvio E (2017) Metformin: clinical use in type 2 diabetes. Diabetologia 60:1586-1593
Hwang, Janice J; Jiang, Lihong; Hamza, Muhammad et al. (2017) Blunted rise in brain glucose levels during hyperglycemia in adults with obesity and T2DM. JCI Insight 2:
Rui, Jinxiu; Deng, Songyan; Arazi, Arnon et al. (2017) ? Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice. Cell Metab 25:727-738
Naik, Sarita; Belfort-DeAguiar, Renata; Sejling, Anne-Sophie et al. (2017) Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone. Diabetes Obes Metab 19:615-621
Jeong, Jaekwang; VanHouten, Joshua N; Dann, Pamela et al. (2016) PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer. Proc Natl Acad Sci U S A 113:E282-90
Belfort-DeAguiar, R; Seo, D; Naik, S et al. (2016) Food image-induced brain activation is not diminished by insulin infusion. Int J Obes (Lond) 40:1679-1686
Kim, Wonnam; Takyar, Farzin M; Swan, Karena et al. (2016) Calcium-Sensing Receptor Promotes Breast Cancer by Stimulating Intracrine Actions of Parathyroid Hormone-Related Protein. Cancer Res 76:5348-60

Showing the most recent 10 out of 47 publications